The school health nurse is discussing weight loss agents with a ...

[daltonest1984]

The school health nurse is discussing weight loss agents with a group of college women at the health promotion session. Which concepts does the nurse include in the teaching plan?
 
  Standard Text: Select all that apply.
  1. Several effective weight loss pills are readily available through telemarketers.
  2. Ephedra is a healthy method for weight reduction and does not require a prescription.
  3. Fenfluramine, one part of the Fen-Phen combination, causes heart disease.
  4. Leptin as a weight-loss medication has not shown to be effective.
  5. Stimulants such as Dexedrine are highly addictive and are no longer prescribed.

Question 2

The nurse is providing education to a client who was taking sibutramine (Meridia) as a part of a weight-loss program. The client asks the nurse why the medication was removed from the market. Which statement by the nurse is most appropriate?
 
  1. Sibutramine (Meridia) was removed from the market due to the adverse effects of postnasal drainage, pruritus, and drowsiness.
  2. Sibutramine (Meridia) was removed from the market due to the adverse effects of headache, constipation, and xerostomia.
  3. Sibutramine (Meridia) was removed from the market to the increased risk of heart attack and stroke.
  4. Sibutramine (Meridia) was removed from the market due to the increased risk for facial twitching, backache, and anxiety.

[yahahah24021]

Answer to Question 1

Correct Answer: 3,4,5
Rationale 1: Telemarketing of pills that produce easy weight loss is usually too good to be true.
Rationale 2: Until 2004, alternative weight loss products contained ephedra alkaloids, but these have also been removed from the market due to an increased incidence of adverse cardiovascular events.
Rationale 3: The substance fenfluramine is suspected of causing heart valvular disease.
Rationale 4: Trials of leptin as a weight-reduction strategy have not proven to be effective.
Rationale 5: Dexedrine, a highly addictive stimulant, is no longer prescribed for weight reduction.
Global Rationale: The substance fenfluramine is suspected of causing heart valvular disease. Trials of leptin as a weight-reduction strategy have not proven to be effective. Dexedrine, a highly addictive stimulant, is no longer prescribed for weight reduction. Telemarketing of pills that produce easy weight loss is usually too good to be true. Until 2004, alternative weight loss products contained ephedra alkaloids, but these have also been removed from the market due to an increased incidence of adverse cardiovascular events.

Answer to Question 2

Correct Answer: 3
Rationale 1: Sibutramine (Meridia) does not cause postnasal drainage, pruritus, and drowsiness.
Rationale 2: Headache, constipation, and xerostomia are common adverse effects of sibutramine (Meridia) but they did not cause the medication to be removed from the market.
Rationale 3: Sibutramine (Meridia) was removed from the market in 2010 due to the increased risk of heart attack and stroke that were associated with the medication.
Rationale 4: Facial twitching, backache, and anxiety are not associated with sibutramine (Meridia).
Global Rationale: From 2007 until 2010, sibutramine (Meridia) was approved for the adjunctive treatment of obesity. The drug was able to produce a 5 to 10 loss of body weight within 6 to 12 months of treatment. Although well tolerated by most patients, sibutramine was found to produce an unacceptable incidence of serious cardiac events and stroke and was voluntarily removed from the market. It did not produce the other effects.

[daltonest1984]

TY

[yahahah24021]

You're welcome